Search research articles
Contact Us
Filters
Showing results (431-440 of 583) with videos related to
Page
of 59
Sort By:
Thorax
|
February 26, 2017
The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
C Echevarria, J Steer, K Heslop-Marshall, et al.
Experimental Hematology & Oncology
|
September 18, 2015
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis
Mary Frances McMullin, Claire N Harrison, Dietger Niederwieser, et al.
Plos One
|
June 5, 2024
Data driven approach to characterize rapid decline in autosomal dominant polycystic kidney disease
John J Sim, Yu-Hsiang Shu, Simran K Bhandari, et al.
Cells
|
August 21, 2019
The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9
Mélissa K Mariani, Pouria Dasmeh, Audray Fortin, et al.
Journal of the American Heart Association
|
February 8, 2025
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction
Hui Zhou, Yiyi Zhang, Matt M Zhou, et al.
Leukemia
|
March 2, 2017
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Physical Review Letters
|
May 23, 2006
Irreversible dynamics of the phase boundary in U(Ru0.96Rh0.04)2Si2 and implications for ordering
A V Silhanek, M Jaime, N Harrison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 2009
Observation of a multiferroic critical end point
Jae Wook Kim, S Y Haam, Y S Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Sociopolitical stress and acute cardiovascular disease hospitalizations around the 2016 presidential election
Matthew T Mefford, Murray A Mittleman, Bonnie H Li, et al.
Leukemia
|
May 24, 2016
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Page
of 59
Search research articles
Search
Showing results (431-440 of 583) with videos related to
Sort By:
Page
of 59
Thorax
|
February 26, 2017
The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
C Echevarria, J Steer, K Heslop-Marshall, et al.
Experimental Hematology & Oncology
|
September 18, 2015
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis
Mary Frances McMullin, Claire N Harrison, Dietger Niederwieser, et al.
Plos One
|
June 5, 2024
Data driven approach to characterize rapid decline in autosomal dominant polycystic kidney disease
John J Sim, Yu-Hsiang Shu, Simran K Bhandari, et al.
Cells
|
August 21, 2019
The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9
Mélissa K Mariani, Pouria Dasmeh, Audray Fortin, et al.
Journal of the American Heart Association
|
February 8, 2025
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction
Hui Zhou, Yiyi Zhang, Matt M Zhou, et al.
Leukemia
|
March 2, 2017
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Physical Review Letters
|
May 23, 2006
Irreversible dynamics of the phase boundary in U(Ru0.96Rh0.04)2Si2 and implications for ordering
A V Silhanek, M Jaime, N Harrison, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 2009
Observation of a multiferroic critical end point
Jae Wook Kim, S Y Haam, Y S Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Sociopolitical stress and acute cardiovascular disease hospitalizations around the 2016 presidential election
Matthew T Mefford, Murray A Mittleman, Bonnie H Li, et al.
Leukemia
|
May 24, 2016
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Page
of 59